Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)

NCT02720757 · clinicaltrials.gov ↗

TERMINATED

Status

132

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment failure

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Spiolto Respimat

Sponsor

Boehringer Ingelheim